Effect of Rev on the intranuclear localization of HIV-1 unspliced RNA

Virology

Volumn 249, Issue 2, 1998, Pages 286-296

  Favaro, Justin P ^a   Borg, Keith T ^a   Arrigo, Salvatore J ^a   Schmidt, Michael G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Confocal microscopy; Nuclear proteins; Nuclear RNA; Rev; RNA splicing

Indexed keywords

REV PROTEIN; VIRUS RNA;

ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROCESSING; RNA TRANSLATION; RNA TRANSPORT; VIRUS CELL INTERACTION;

EID: 0032582008     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9312     Document Type: Article

References (61)

1. Arrigo S. J., Chen I. S. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev. 5:1991;808-819.
2. Arrigo S. J., Weitsman S., Rosenblatt J. D., Chen I. S. Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method. J. Virol. 63:1989;4875-4881.
3. Bachellerie J. P., Puvion E., Zalta J. P. Ultrastructural organization and biochemical characterization of chromatin-RNA-protein complexes isolated from mammalian cell nuclei. Eur. J. Biochem. 58:1975;327-337.
4. Berthold E., Maldarelli F. cis-acting elements in human immunodeficiency virus type 1 RNAs direct viral transcripts to distinct intranuclear lcoations. J. Virol. 70:1996;4667-4682.
5. B'e S.-O., Bj'rndal B., R'sok B., Szilvay A. M., Kalland K.-H. Subcellular localization of human immunodeficiency virus Type 1 RNAs, Rev, and the splicing factor SC-35. Virology. 244:1998;473-482.
6. Bogerd H. P., Fridell R. A., Madore S., Cullen B. R. Identification of a novel cellular cofactor of the Rev/Rex class of retroviral regulatory proteins. Cell. 82:1995;485-494.
7. Campbell L. H., Borg K. T., Arrigo S. J. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 (HIV-1) Rev-responsive element. Virology. 219:1996;423-431.
8. Chang D. D., Sharp P. A. Regulation by HIV Rev depends upon recognition of splice sites. Cell. 59:1989;789-795.
9. Clemson C. M., Lawrence J. B. Multifunctional compartments in the nucleus: Insights from DNA and RNA localization. J. Cell. Biochem. 62:1996;181-190.
10. Cochrane A. W., Chen C. H., Rosen C. A. Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA. Proc. Natl. Acad. Sci. USA. 87:1990;1198-1202.
11. Cochrane A. W., Jones K. S., Beidas S., Dillon P. J., Skalka A. M., Rosen C. A. Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J. Virol. 65:1991;5305-5313.
12. Company M., Arenas J., Abelson J. Requirement of the RNA helicase-like protein PRP22 for release of messenger RNA from spliceosomes [see comments]. Nature. 349:1991;487-493.
13. Dagostino D. M., Felber B. K., Harrison J. E., Pavlakis G. N. The Rev protein of human immunodeficiency virus Type-1 promotes polysomal association and translation of gag/pol and vpu/env messenger RNAs. Mol. Cell. Biol. 12:1992;1375-1386.
14. Daly T. J., Cook K. S., Gray G. S., Maione T. E., Rusche J. R. Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature. 342:1989;816-819.
15. Dayton A. I. The Rev axis of HIV-1 and its associated host cofactors: A viral window onto the workings of eukaryotic posttranscriptional RNA processing. J. Biomed. Sci. 3:1996;69-77.
16. Emerman M., Vazeux R., Peden K. The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. Cell. 57:1989;1155-1165.
17. Fakan S. Perichromatin fibrils arein situ. Trends Cell Biol. 4:1994;86-90.
18. Fakan S., Puvion E. The ultrastructural visualization of nucleolar and extranucleolar RNA synthesis and distribution. Int. Rev. Cytol. 65:1980;255-299.
19. Favaro J. P., Arrigo S. J. Characterization of Rev function using subgenomic and genomic constructs in T and COS cells. Virology. 228:1997;29-38.
20. Feinberg M. B., Jarrett R. F., Aldovini A., Gallo R. C., Wong S. F. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell. 46:1986.
21. Felber B. K., Hadzopoulou C. M., Cladaras C., Copeland T., Pavlakis G. N. rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA. 86:1989;1495-1499.
22. Fischer U., Huber J., Blelens W. C., Mattaj I. W., Luhrmann R. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell. 82:1995;475-483.
23. Fischer U., Meyer S., Teufel M., Heckel C., Luhrmann R., Rautmann G. Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA. EMBO. J. 13:1994;4105-4112.
24. Fornerod M., Ohno M., Yoshida M., Mattaj I. W. CRM1 is an export receptor for leucine-rich nuclear export signals [see comments]. Cell. 90:1997;1051-1060.
25. Fritz C. C., Zapp M. L., Green M. R. A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature. 376:1995;530-533.
26. Fu X. D., Maniatis T. Factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus. Nature. 343:1990;437-441.
27. Ge H., Manley J. L. A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro. Cell. 62:1990;25-34.
28. Green M. R. Pre-mRNA splicing. Annu. Rev. Genet. 20:1986;671-708.
29. Hammarskjold M. L., Heimer J., Hammarskjold B., Sangwan I., Albert L., Rekosh D. Regulation of human immunodeficiency virus env expression by the rev gene product. J. Virol. 63:1989;1959-1966.
30. Hammarskjold M. L., Li H., Rekosh D., Prasad S. Human immunodeficiency virus env expression becomes Rev-independent if the env region is not defined as an intron. J. Virol. 68:1994;961-968.
31. Heaphy S., Dingwall C., Ernberg I., Gait M. J., Green S. M., Karn J., Lowe A. D., Singh M., Skinner M. A. HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region. Cell. 60:1990;685-693.
32. Huang S., Spector D. L. Intron-dependent recruitment of pre-mRNA splicing factors to sites of transcription. J. Cell Biol. 133:1996;719-732.
33. Huang Y., Carmichael G. C. role of polyadenylation in nucleocytoplasmic transport of mRNA. Mol. Cell. Biol. 16:1996;1534-1542.
34. Jimenez-Garcia L. F., Spector D. L. In vivo evidence that transcription and splicing are coordinated by a recruiting mechanism. Cell. 73:1993;47-59.
35. Johnson C. V., Singer R. H., Lawrence J. B. Fluorescent detection of nuclear RNA and DNA: Implications for genome organization. Methods Cell Biol. 35:1991;73-99.
36. Kimura T., Hashimoto I., Nishikawa M., Fujisawa J. I. A role for Rev in the association of HIV-1 gag mRNA with cytoskeletal beta-actin and viral protein expression. Biochim. (Paris). 78:1996;1075-1080.
37. Kjems J., Frankel A. D., Sharp P. A. Specific regulation of messenger RNA splicing invitro by a peptide from HIV-1 Rev. Cell. 67:1991;169-178.
38. Kjems J., Sharp P. A. The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleotprotein in spliceosome assembly. J. Virol. 67:1993;4769-4776.
39. Krainer A. R., Mayeda A., Kozak D., Binns G. Functional expression of cloned human splicing factor SF2; homology to RNA-binding proteins, U1 70K, and Drosophila splicing regulators. Cell. 66:1991;383-394.
40. Kramer A. The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu. Rev. Biochem. 65:1996;367-409.
41. Lawrence J. B., Cochrane A. W., Johnson C. V., Perkins A., Rosen C. A. The HIV-1 Rev protein: A model system for coupled RNA transport and translation. New Biol. 3:1991;1220-1232.
42. Malim M. H., Bohnlein S., Fenrick R., Le S. Y., Maizel J. V., Cullen B. R. Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species. Proc. Natl. Acad. Sci. USA. 86:1989a;8222-8226.
43. Malim M. H., Bohnlein S., Hauber J., Cullen B. R. functional dissection of the HIV-1 Rev trans-activator-derivation of a trans-dominant repressor of Rev function. Cell. 58:1989b;205-214.
44. Malim M. H., Hauber J., Le S. Y., Maizel J. V., Cullen B. R. the HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature. 338:1989c;254-257.
45. Malim M. H., Tiley L. S., McCarn D. F., Rusche J. R., Hauber J., Cullen B. R. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell. 60:1990;675-683.
46. McGahon A. J., Martin S. J., Bissonnette R. P., Mahboubi A., Shi Y., Mogil R. J., Nishioka W. K., Green D. R. The end of the (cell) line: Methods for the study of apoptosis in vitro. Methods Cell Biol. 46:1995;153-185.
47. Misteli T., Caceres J. F., Spector D. L. The dynamics of a pre-mRNA splicing factor in living cells. Nature. 387:1997;523-527.
48. Molnar G. M., Crozat A., Kraeft S. K., Dou Q. P., Chen L. B., Pardee A. B. Association of the mammalian helicase MAH with the pre-mRNA splicing complex. Proc. Natl. Acad. Sci. USA. 94:1997;7831-7836.
49. Nickerson J. A., Blencowe B. J., Penman S. the architectural organization of nuclear metabolism. Int. Rev. Cytol. 162A:1995;67-123.
50. Olsen H. S., Cochrane A. W., Dillon P. J., Nalin C. M., Rosen C. A. Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids. Genes Dev. 4:1990a;1357-1364.
51. Olsen H. S., Nelbock P., Cochrane A. W., Rosen C. A. Secondary structure is the major determinant for interaction of HIV rev protein with RNA. Science. 247:1990b;845-848.
52. Padgett R. H., Grabowski P. J., Konsarka M. M., Seiler S., Sharp P. A. Splicing of messenger RNA precursors. Annu. Rev. Biochem. 55:1986;1119-1150.
53. Perkins A., Cochrane A. W., Ruben S. M., Rosen C. A. Structural and functional characterization of the human immunodeficiency virus rev protein. J. Acquir. Immune Defic. Syndr. 2:1989;256-263.
54. Powell D. M., Amaral M. C., Wu J. Y., Maniatis T., Greene W. C. HIV Rev-dependent binding of SF2/ASF to the Rev response element: Possible role in Rev-mediated inhibition of HIV RNA splicing. Proc. Natl. Acad. Sci. USA. 94:1997;973-978.
55. Sodroski J., Goh W. C., Rosen C., Dayton A., Terwilliger E., Haseltine W. A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature. 321:1986;412-417.
56. Spector D. L. Macromolecular domains within the cell nucleus. Annu. Rev. Cell Biol. 9:1993;265-315.
57. Stutz F., Neville M., Rosbash M. Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 Rev protein in yeast. Cell. 82:1995;495-506.
58. Tange T. O., Jensen T. H., Kjems J. In vitro interaction between human immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2-associated protein, p32. J. Biol. Chem. 271:1996;10066-10072.
59. Wen W., Meinkoth J. L., Tsien R. Y., Taylor S. S. Identification of a signal for rapid export of proteins from the nucleus. Cell. 82:1995;463-473.
60. Zapp M. L., Green M. R. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature. 342:1989;714-716.
61. Zhang G., Zapp M. L., Yan G., Green M. R. Localization of HIV-1 RNA in mammalian nuclei. J. Cell Biol. 135:1996;9-18.